List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 650 studies with search of: "hematopoietic stem cell transplantation"
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed Hematopoietic Stem Cell Transplantation for the Treatment of Limb Ischemia and Diabetic Neuropathy
Conditions: Limb Ischemia;   Diabetic Neuropathy
Intervention: Biological: Hematopoietic stem cell transplantation
2 Recruiting A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors
Condition: Hematological Malignancies
Interventions: Radiation: Total Body Irradiation;   Drug: Cyclophosphamide;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Drug: Fludarabine;   Drug: Thiotepa;   Genetic: Hematopoietic stem cell transplantation
3 Active, not recruiting GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients
Conditions: Amenorrhea;   Premature Ovarian Failure;   Ovarian Function Insufficiency
Interventions: Drug: Leuprolide Acetate;   Behavioral: Questionnaire;   Procedure: Hematopoietic Stem Cell Transplantation
4 Recruiting Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors
Condition: Hematologic Neoplasms
Interventions: Drug: Cyclophosphamide;   Other: Hematopoietic Stem Cell Transplantation,
5 Completed Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H
Conditions: Leukemia, Myeloid, Acute;   Leukemia, Lymphoblastic, Acute
Interventions: Procedure: Haploidentical hematopoietic stem cell transplantation;   Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: CAMPATH-1H;   Drug: Cyclosporin A;   Drug: Methotrexate
6 Recruiting Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy
Condition: Polyneuropathy
Intervention: Biological: hematopoietic stem cell transplantation
7 Recruiting Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia
Condition: Fanconi Anemia
Interventions: Biological: anti-thymocyte globulin;   Biological: filgrastim;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Drug: methylprednisolone;   Biological: Hematopoietic stem cell transplantation
8 Recruiting Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis
Condition: Scleroderma
Intervention: Biological: Hematopoietic stem cell transplantation
9 Active, not recruiting Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia;   Contiguous Stage II Small Lymphocytic Lymphoma;   Noncontiguous Stage II Small Lymphocytic Lymphoma;   Prolymphocytic Leukemia;   Recurrent Small Lymphocytic Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Stage I Chronic Lymphocytic Leukemia;   Stage I Small Lymphocytic Lymphoma;   Stage II Chronic Lymphocytic Leukemia;   Stage II Small Lymphocytic Lymphoma;   Stage III Chronic Lymphocytic Leukemia;   Stage III Small Lymphocytic Lymphoma;   Stage IV Chronic Lymphocytic Leukemia;   Stage IV Small Lymphocytic Lymphoma
Interventions: Drug: fludarabine phosphate;   Drug: cyclosporine;   Drug: mycophenolate mofetil;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Procedure: hematopoietic stem cell transplantation;   Other: flow cytometry;   Genetic: polymerase chain reaction;   Radiation: total-body irradiation;   Other: laboratory biomarker analysis;   Procedure: bone marrow aspiration
10 Unknown † Hematopoietic Stem Cell Transplantation in Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Procedure: Autologous hematopoietic stem cell transplantation
11 Completed Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Interventions: Biological: anti-thymocyte globulin;   Drug: busulfan;   Drug: fludarabine phosphate;   Drug: leucovorin calcium;   Drug: methotrexate;   Procedure: allogeneic bone marrow transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation
12 Terminated Hematopoietic Stem Cell Transplantation in Autoimmune-Related Retinopathy(ARRON)
Condition: Retinal Disease
Intervention: Biological: Hematopoietic stem cell transplantation.
13 Recruiting Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells
Conditions: Sickle Cell Disease;   Thalassemia;   Anemia;   Granuloma;   Wiskott-Aldrich Syndrome;   Chediak Higashi Syndrome;   Osteopetrosis;   Neutropenia;   Thrombocytopenia;   Hurler Disease;   Niemann-Pick Disease;   Fucosidosis
Intervention: Procedure: Hematopoietic stem cell transplantation
14 Completed Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer
Conditions: Chronic Myeloproliferative Disorders;   Graft Versus Host Disease;   Infection;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Precancerous Condition;   Secondary Myelofibrosis;   Small Intestine Cancer
Interventions: Biological: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: fludarabine phosphate;   Drug: melphalan;   Drug: methotrexate;   Drug: sirolimus;   Drug: tacrolimus;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: hematopoietic stem cell transplantation;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: total-body irradiation
15 Recruiting A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Conditions: Hematologic Malignancies;   Acute Leukemia;   Myelodysplastic Syndrome (MDS);   Specific Subtypes of Refractory Anemia (RA) or Refractory Anemia With Ringed Sideroblasts(RARS) Subtypes;   Myeloproliferative Disorder (MPD);   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Myeloma;   Aplastic Anemia
Interventions: Drug: Fludarabine;   Drug: Thiotepa;   Radiation: Total Body Irradiation (TBI);   Biological: Donor Lymphocyte Infusion (DLI);   Drug: Cyclophosphamide (CY);   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Device: Hematopoietic stem cell transplantation
16 Recruiting Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD
Conditions: Graft Versus Host Disease;   Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: Fludarabine Phosphate;   Drug: Tacrolimus;   Drug: Thiotepa;   Radiation: Total-Body Irradiation (TBI);   Other: Magnetic Affinity Cell Sorting;   Procedure: Peripheral Blood Stem Cell Transplantation;   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Biological: T Cell-Depleted Hematopoietic Stem Cell Transplantation
17 Recruiting Yttrium Y 90 Ibritumomab Tiuxetan, Rituximab, Indium In-111 Ibritumomab Tiuxetan, Fludarabine, Melphalan, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin Lymphoma
Conditions: Graft Versus Host Disease;   Leukemia;   Lymphoma
Interventions: Biological: rituximab;   Drug: fludarabine phosphate;   Drug: melphalan;   Drug: sirolimus;   Drug: tacrolimus;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Radiation: indium In 111 ibritumomab tiuxetan;   Radiation: yttrium Y 90 ibritumomab tiuxetan
18 Recruiting Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
Condition: Lymphoma
Interventions: Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: gemcitabine hydrochloride;   Drug: ifosfamide;   Drug: mechlorethamine hydrochloride;   Drug: melphalan;   Drug: methotrexate;   Drug: mycophenolate mofetil;   Drug: prednisone;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate;   Drug: vinorelbine tartrate;   Procedure: allogeneic bone marrow transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: umbilical cord blood transplantation;   Radiation: total-body irradiation
19 Completed Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation
Condition: Hematologic Malignancies
Interventions: Drug: L-leucyl-L-leucine Methyl Ester (LLME);   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Cyclophosphamide;   Drug: Tacrolimus;   Drug: Mesna;   Biological: Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF);   Procedure: Hematopoietic stem cell transplantation (HSCT)
20 Completed Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome
Condition: Wiskott-Aldrich Syndrome
Interventions: Procedure: Hematopoietic stem cell transplantation;   Device: Miltenyi CliniMACS selection system;   Drug: Fludarabine, Melphalan, Thiotepa

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services